Publisher： John Wiley & Sons Inc
E-ISSN： 1440-1681|42|5|458-464
ISSN： 0305-1870
Source： CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ELECTRONIC), Vol.42, Iss.5, 2015-05, pp. : 458-464
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Increased Expression of EZH2, a Polycomb Group Protein, in Bladder Carcinoma
Urologia Internationalis, Vol. 75, Iss. 3, 2005-10 ,pp. :
Access to resources
Recommend
Therapeutic Polycomb Targeting in Human Cancer
Recent Patents on Regenerative Medicine, Vol. 2, Iss. 1, 2012-01 ,pp. :
VEGF as a Therapeutic Target in Cancer
Oncology, Vol. 69, Iss. 3, 2005-11 ,pp. :
Systemic GLIPR1‐ΔTM protein as a novel therapeutic approach for prostate cancer
INTERNATIONAL JOURNAL OF CANCER, Vol. 134, Iss. 8, 2014-04 ,pp. :